Children’s National Hospital
cbtn
Principal Investigators
Scientific Committee
Executive Board
Executive co-Chair
Principal Investigator
Brian Rood, MD
Brian R. Rood, MD, is an Associate Professor of Pediatrics in the Center for Cancer and Blood Disorders at Children’s National Hospital whose primary clinical focus is pediatric neuro-oncology. Dr. Rood joined the faculty of Children’s National in 2002 after completing a fellowship in Pediatric Hema
Scientific Committee
Executive Board
Principal Investigator
Javad Nazarian, PhD, MSc
I am an investigator at the Center for Genetic Medicine in Children’s National Hospital in Washington, D.C., and an assistant professor in Integrative Systems Biology at the George Washington University. I received my PhD from the George Washington University in Genetics in 2005. My dissertation res
about this
Institution
Each year, the Brain Tumor Institute at Children’s National evaluates more than 100 new patients with brain tumors, and is recognized as a world leader in childhood brain tumor care and research. Children’s National has pioneered novel pediatric brain tumor therapies, including new molecularly-targeted therapies, vaccines, T-cell immunotherapies, and less invasive techniques. They are currently ranked #6 among children’s cancer hospitals by U.S News & World Report.
Children treated at Children’s National Hospital have access to the latest, most effective treatments for brain tumors, and are cared for by a multidisciplinary team of experts in both neurology and oncology, who are committed to saving lives and providing the best possible care for children with brain tumors.
meet the
Team
Scientific Committee
Eugene Hwang, MD
Eugene (Gene) Hwang, M.D., is part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials
Scientific Committee
Robert Keating, MD
Robert Keating, M.D., is currently Professor and Chief of Neurosurgery at Children’s National Hospital. A graduate of Georgetown University Medical School, he completed a neurosurgery residency and fellowship in pediatric neurosurgery/craniofacial surgery at the Albert Einstein and Montefiore Medica
Scientific Committee
Miriam Bornhorst, MD
Brain tumors, Cancer genetics, Neurofibromatosis
Samuel Rivero-Hinojosa, PhD
Samuel Rivero-Hinojosa, Ph.D., is a Staff Scientist at the Children’s National Research Institute focused on pediatric brain tumors. He is interested on integrative bioinformatics for Genomic and Proteomics to discover the functional biology and new treatment options for childhood brain tumors. He h
Site Coordinator
Augustine Eze, MS
My name is Augustine Eze and I have the privilege of serving as the interim Children’s Brain Tumor Network coordinator at Children’s National Hospital. I completed both my undergraduate degree in Biology, concentrating in Global Health, and my masters degree in Physiology and Biophysics at Georgetow
Scott Raskin, DO
Dr. Scott I. Raskin is a pediatrician in Washington, District of Columbia and is affiliated with Children's National Hospital. He received his medical degree from Western University College of Osteopathic Medicine of the Pacific and has been in practice between 3-5 years.
Scientific co-Chair
Roger Packer, MD
Dr. Packer has been heavily involved in clinical and applied basic science research. His clinical research has touched on various aspects of adult and child neurology and neuro-oncology, including adult and pediatric brain tumors, neurofibromatosis type 1, the neurologic aspects of childhood neurog